Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis

Browse by...

Deposit

Highlights

More informations

Title		Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis
Authors		Didden, Eva-Maria Ruffieux, Yann Hummel, Noemi Efthimiou, Orestis Reichenbach, Stephan Gsteiger, Sandro Finckh, Axel Fletcher, Christine Salanti, Georgia Egger, Matthias show all authors [1 - 10]
Published in		Medical Decision Making. 2018, vol. 38, no. 6, p. 719-729
Abstract		Decision makers often need to assess the real-world effectiveness of new drugs prelaunch, when phase II/III randomized controlled trials (RCTs) but no other data are available.
Identifiers		DOI: 10.1177/0272989X18775975 PMID: 30074882
Full text		Article (Published version) (416 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research group		Mécanisme de l'inflammation articulaire (44)
Citation (ISO format)		DIDDEN, Eva-Maria et al. Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. In: Medical Decision Making, 2018, vol. 38, n° 6, p. 719-729. https://archive-ouverte.unige.ch/unige:110686